MRA

Mutual Recognition Agreement (MRA) is an agreement between FDA and foreign regulatory authorities that allows drug inspectors to rely upon information from drug inspections conducted within each other’s borders. FDA has MRAs in force with the European Union, Switzerland, and the United Kingdom.